Correlation Between Virax Biolabs and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and InMed Pharmaceuticals, you can compare the effects of market volatilities on Virax Biolabs and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and InMed Pharmaceuticals.
Diversification Opportunities for Virax Biolabs and InMed Pharmaceuticals
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virax and InMed is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virax Biolabs and InMed Pharmaceuticals
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.11 times more return on investment than InMed Pharmaceuticals. However, Virax Biolabs is 1.11 times more volatile than InMed Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.2 per unit of risk. If you would invest 224.00 in Virax Biolabs Group on August 31, 2024 and sell it today you would lose (17.00) from holding Virax Biolabs Group or give up 7.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. InMed Pharmaceuticals
Performance |
| Timeline |
| Virax Biolabs Group |
| InMed Pharmaceuticals |
Virax Biolabs and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and InMed Pharmaceuticals
The main advantage of trading using opposite Virax Biolabs and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |